Search Results

Association of Combination of Conformation-Specific KIT Inhibitors With Clinical Benefit in Patients With Refractory Gastrointestinal Stromal Tumors: A Phase 1b/2a Nonrandomized Clinical Trial.

• Authors : Wagner, Andrew J.; Severson, Paul L.; Shields, Anthony F.

• Source: JAMA Oncology; Sep2021, Vol. 7 Issue 9, p1343-1350, 8p

Record details

Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial.

• Authors : Tap, William D.; Wagner, Andrew J.; Schöffski, Patrick

Subjects: THERAPEUTIC use of antineoplastic agents; ANTINEOPLASTIC antibiotics; RESEARCH

• Source: JAMA: Journal of the American Medical Association; 4/7/2020, Vol. 323 Issue 13, p1266-1276, 11p

Record details

Low Levels of Evidence for Neoadjuvant Chemotherapy to Treat Soft-Tissue Sarcoma.

• Authors : George, Suzanne; Wagner, Andrew J.

• Source: JAMA Oncology; Sep2018, Vol. 4 Issue 9, p1169-1170, 2p

Record details

Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series.

• Authors : Frezza AM; Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale Tumori, Milano, Italy.; Jones RL

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Sarcoma/Sarcoma/Sarcoma/*drug therapy; Adolescent

• Source: JAMA oncology [JAMA Oncol] 2018 Sep 01; Vol. 4 (9), pp. e180219. Date of Electronic Publication: 2018 Sep 13.Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model:

Record details